4‐Formyl‐N‐Methylpyridinium‐Mediated N‐Terminal Cysteine Modification/Removal Facilitates One‐Pot Multiplex Peptide Ligation
Abstract
ABSTRACT The chemical synthesis of proteins with site‐specific modifications remains a fundamental challenge in chemical biology. One‐pot peptide ligation strategies have emerged as powerful tools to enhance synthetic efficiency, primarily relying on N‐terminal cysteine (Cys) protection. However, current Cys deprotection conditions require various reagents or pH adjustments during the reaction, rendering downstream processing cumbersome. Here, a visible‐light‐mediated deprotection strategy using 2‐(N‐methylpyridinium‐4‐yl)‐thiazolidine (4‐NMP‐Thz) as a novel N‐terminal Cys‐protecting group is reported. This reaction, catalyzed by [Ru(bpy) 3 ]Cl 2 at physiological pH (6.0–8.0), enables smooth one‐pot multi‐segment peptide assembly. The strategy demonstrates complete orthogonality to native chemical ligation (NCL) and desulfurization conditions, eliminating the requirement for intermediate purification or pH adjustment. This methodology was used to facilitate an efficient one‐pot synthesis of a 400‐amino acid (aa) glycosylated MUC1 glycoprotein bearing 40 O‐glycosyl modifications that is difficult to prepare using previously reported techniques. The 400‐aa MUC1 significantly enhanced antigenic immunogenicity compared with shorter MUC1 glycopeptides. This streamlined approach establishes a robust platform for the construction of complex post‐translationally modified proteins.
Article Details
Authors (8)
Bingcheng Wei
Center for Chemical Glycobiology, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering
Xinyao Wang
Biomedical Pioneering Innovation Center
Farong Ye
Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Zhangjiang Institute for Advanced Study, School of Pharmaceutical Sciences
Haozhan Wang
The First Affiliated Hospital of Harbin Medical University, School of Stomatology Harbin Medical University Harbin China
Gongyu Shi
Center For Chemical Glycobiology Shanghai Key Laboratory For Antibody‐Drug Conjugates With Innovative Target National Key Laboratory of Innovative Immunotherapy Zhangjiang Institute for Advanced Study School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai China
Bing Liu
Ping Huang
Ping Wang